Obiettivo
The ultimate goal of our Consortium is to generate the necessary data to allow xenotransplantation to progress towards its initial clinical phase. The data generated during this project will encompass both efficacy and safety aspects of xeno-transplantation. Tools that will be used to reach this ambitious objective encompass state-of-the-art biomolecular technologies and in vivo models. XENOME aims to produce a "super-engineered" pig, i.e. a pig with a newly generated genotype that will improve the efficacy and safety profile of xenotransplantation. Assessments of efficacy will first take advantage of existing pig lines expressing human complement regulators, thrombomodulin (TM) and knock-out for a-Gal transferase. Using the most suitable background, further engineering will eliminate one or more PERV sequences. Additional transgenes, such as HO-1, CD39 and other molecules able to control immune responses, endothelial cell activation and subsequent microangiopathy, will be added.
The ultimate pig strain will thus combine the already available background with novel molecules exhibiting anti-inflammatory, anticoagulant and immunosuppressive properties. In addition, an effective immuno-suppression regimen will be defined and new pharmaceutical agents will be tested. A strong safety framework will also be established that may allow, at some stage, progression of xenotransplantation into the clinic. This will involve development of technologies enabling the timely diagnosis of infection, design of a safety plan for an efficacious containment of an untoward infectious event, breeding of a herd of "clean" source pigs, inactivation of PERV sequences and provide safety-related data deriving from long-term in vivo studies in primate xenograft recipients. Finally, the project will also provide a strong ethical, social (especially regarding public communication) and regulatory framework for xenotransplantation research (and possibly clinical application).
Campo scientifico
Invito a presentare proposte
FP6-2005-LIFESCIHEALTH-6
Vedi altri progetti per questo bando
Meccanismo di finanziamento
IP - Integrated ProjectCoordinatore
PADOVA
Italia
Mostra sulla mappa
Partecipanti (25)
TORQUAY
Mostra sulla mappa
NANTES
Mostra sulla mappa
LEIOA (BIZKAIA)
Mostra sulla mappa
VIENNA
Mostra sulla mappa
LONDON
Mostra sulla mappa
NEUSTADT
Mostra sulla mappa
GLASGOW
Mostra sulla mappa
LA SERRA DI SAN MINIATO (PI)
Mostra sulla mappa
PRAGUE
Mostra sulla mappa
30623 HANNOVER
Mostra sulla mappa
PADUA
Mostra sulla mappa
CAMBRIDGE
Mostra sulla mappa
KONSTANZ
Mostra sulla mappa
PADOVA
Mostra sulla mappa
UPPSALA
Mostra sulla mappa
COIMBRA
Mostra sulla mappa
LISBOA
Mostra sulla mappa
9600 LEIDEN
Mostra sulla mappa
GLASGOW
Mostra sulla mappa
PARIS
Mostra sulla mappa
GREIFSWALD, INSEL RIEMS
Mostra sulla mappa
CREMONA
Mostra sulla mappa
MILANO
Mostra sulla mappa
MILAN
Mostra sulla mappa
OTTIGNIES LOUVAIN-LA-NEUVE
Mostra sulla mappa